HOXB‐AS3/EZH2 complex–mediated Dicer suppression plays an important role in sorafenib resistance and cancer stemness and provides potential therapeutic strategies for diagnosing and treating liver cancer patients. This evidence concerns the gene EZH2 and cancer.